Novartis
NVS
#56
Rank
โ‚ฌ217.75 B
Marketcap
113,49ย โ‚ฌ
Share price
-0.20%
Change (1 day)
22.31%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Earnings for Novartis (NVS)

Earnings in 2025 (TTM): โ‚ฌ14.64 Billion

According to Novartis's latest financial reports the company's current earnings are โ‚ฌ56.37 Billion. In 2024 the company made an earning of โ‚ฌ11.71 Billion, an increase over its 2023 earnings that were of โ‚ฌ7.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novartis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ14.64 B25.07%
2024 โ‚ฌ11.71 B49.51%
2023 โ‚ฌ7.83 B13.48%
2022 โ‚ฌ6.90 B-69.24%
2021 โ‚ฌ22.44 B164.6%
2020 โ‚ฌ8.48 B10.49%
2019 โ‚ฌ7.67 B-36.26%
2018 โ‚ฌ12.04 B55.86%
2017 โ‚ฌ7.72 B15.12%
2016 โ‚ฌ6.71 B-3.9%
2015 โ‚ฌ6.98 B-33.72%
2014 โ‚ฌ10.53 B14.87%
2013 โ‚ฌ9.17 B-2.93%
2012 โ‚ฌ9.44 B2.15%
2011 โ‚ฌ9.25 B-7.94%
2010 โ‚ฌ10.04 B17.94%
2009 โ‚ฌ8.52 B4.45%
2008 โ‚ฌ8.15 B27.5%
2007 โ‚ฌ6.39 B-6.31%
2006 โ‚ฌ6.82 B9.46%
2005 โ‚ฌ6.23 B5.17%
2004 โ‚ฌ5.93 B13.84%
2003 โ‚ฌ5.21 B-38.51%
2002 โ‚ฌ8.47 B574.04%
2001 โ‚ฌ1.25 B83%
2000 โ‚ฌ0.68 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
โ‚ฌ19.82 B 40.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.17 B-27.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.81 B 97.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.81 B-44.57%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚ฌ8.00 B-43.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.52 B-89.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B-51.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ6.98 B-50.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.24 B-20.28%๐Ÿ‡ฌ๐Ÿ‡ง UK